ArticleTherapeutics and clinical risk management2015

Cancer risk in patients aged 30 years and above with type 2 diabetes receiving antidiabetic monotherapy: a cohort study using metformin as the comparator.

Yu-Ching Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.